Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care

To determine the influence of anticholinergic medications on transitions in cognitive diagnosis of older adults in primary care.

[1]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[2]  E. Perry,et al.  Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs , 2003, Annals of neurology.

[3]  Cornelius Katona,et al.  Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study , 2011, Journal of the American Geriatrics Society.

[4]  B. Guthrie,et al.  Temporal trends in anticholinergic medication prescription in older people: repeated cross-sectional analysis of population prescribing data. , 2014, Age and ageing.

[5]  Clifford R Jack,et al.  Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. , 2016, JAMA neurology.

[6]  M. Boustani,et al.  Impact of anticholinergics on the aging brain: a review and practical application , 2008 .

[7]  M. Boustani,et al.  Long-term anticholinergic use and the aging brain , 2013, Alzheimer's & Dementia.

[8]  Knut Engedal,et al.  Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[9]  Paula Moyano,et al.  Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels , 2015, Archives of Toxicology.

[10]  M. Boustani,et al.  Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population , 2016, Pharmacotherapy.

[11]  M. Boustani,et al.  Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. , 2014, Age and ageing.

[12]  K. Sivaprakasam.  Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation. , 2006, Current medicinal chemistry.

[13]  M. Mesulam,et al.  Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine , 2002, Neuroscience.

[14]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[15]  M. Higbee,et al.  Geriatric Dosage Handbook , 2001 .

[16]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[17]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[18]  et al.,et al.  The Regenstrief Medical Record System: a quarter century experience , 1999, Int. J. Medical Informatics.

[19]  J. Touchon,et al.  Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study , 2006, BMJ : British Medical Journal.

[20]  C. Rowe,et al.  Effects of Anticholinergic Drugs on Cognitive Function in Older Australians: Results from the AIBL Study , 2011, Dementia and Geriatric Cognitive Disorders.

[21]  Sascha Dublin,et al.  Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. , 2015, JAMA internal medicine.

[22]  J. Hanlon,et al.  Racial differences in anticholinergic use among community-dwelling elders. , 2015, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

[23]  M. Boustani,et al.  The 2012 update to the anticholinergic cognitive burden scale , 2013 .

[24]  Bohn Stafleu van Loghum,et al.  Online … , 2002, LOG IN.

[25]  M. K. Ward,et al.  Sympathetic Sprouting Drives Hippocampal Cholinergic Reinnervation That Prevents Loss of a Muscarinic Receptor-Dependent Long-Term Depression at CA3–CA1 Synapses , 2006, The Journal of Neuroscience.

[26]  M. Ryan,et al.  Long-term cognitive impact of anticholinergic medications in older adults. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[27]  R. Hubbard,et al.  Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study , 2016, British Medical Journal.

[28]  Alzheimer's Disease Neuroimaging Initiative.  Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults , 2016 .

[29]  J. Weuve,et al.  2016 Alzheimer's disease facts and figures , 2016 .

[30]  Sarah N Hilmer,et al.  Drug Burden Index and Potentially Inappropriate Medications in Community-Dwelling Older People , 2010, Drugs & aging.

[31]  P. Nishtala,et al.  Associations of drug burden index with falls, general practitioner visits, and mortality in older people , 2014, Pharmacoepidemiology and drug safety.

[32]  A. Hake,et al.  Mild cognitive impairment, incidence, progression, and reversion: findings from a community-based cohort of elderly African Americans. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[33]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[34]  F. LaFerla,et al.  M1 Receptors Play a Central Role in Modulating AD-like Pathology in Transgenic Mice , 2006, Neuron.

[35]  Changiz Geula,et al.  Abnormalities of neural circuitry in Alzheimer's disease , 1998, Neurology.

[36]  G. Livingston,et al.  The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study. , 2011, Age and ageing.

[37]  K. Davis,et al.  Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.

[38]  M. Boustani,et al.  Use of anticholinergics and the risk of cognitive impairment in an African American population , 2010, Neurology.